Project sponsor

CND Life Sciences

Since our founding, CND Life Sciences has been on a mission to advance the care of patients who face the potential diagnosis of a neurodegenerative disease. With long careers in research and clinical care, our founders  set out to unlock  deeper stories within the skin by  detecting key pathological markers in the peripheral nervous system that had been previously out of reach.

Website

Spring 2026

Automated Coverslipping Design to Prevent Image Disturbances in Tissue Scans Used for Neurological Disorder Diagnosis

Our concept works to prevent image disturbances in pathology scans by automating the Coverslipping process. The design will reproduce the slide preparation process using robotic automation, applying the appropriate PBS solution and a coverslip. CND Life Sciences aids in the diagnosis of Parkinson’s through skin biopsy to successfully provide a diagnosis before clinical onset. Current…

Automated Skin Punch Biopsy Tool

The Syn-One skin punch biopsy test, developed by CND Life Sciences, provides pathological evidence for Parkinson’s disease, dementia with Lewy bodies, and related synucleinopathies. However, a 20-month review revealed high rates of unusable samples due to technique variability. The current multi-instrument workflow requires tweezers, a metal push rod, and a standard punch tool, contributing to…

Spring 2026

Automated Coverslipping Design to Prevent Image Disturbances in Tissue Scans Used for Neurological Disorder Diagnosis

Automated Skin Punch Biopsy Tool

Fall 2025

Automated Coverslipping Design to Prevent Image Disturbances in Tissue Scans Used for Neurological Disorder Diagnosis

Automated Skin Punch Biopsy Tool